Nuveen’s Achillion Pharmaceuticals ACHN Stock Holding History

Nuveen’s Portfolio ACHN Stock Details ACHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,312,109	Closed	-$7.91M	–	3311
2019 Q4	$7.91M	Sell	1,312,109 -1,840,177	-58%	-$10.7M	﹤0.01%	1729
2019 Q3	$11.3M	Buy	3,152,286 +239,682	+8%	+$924K	﹤0.01%	1483
2019 Q2	$7.8M	Buy	+2,912,604	New	+$8.6M	﹤0.01%	1752
2013 Q3	–	Sell	-113,162	Closed	-$926K	–	1587
2013 Q2	$926K	Buy	+113,162	New	+$864K	0.01%	1066

Nuveen's ACHN Position: Q1 2020 in Review

Nuveen sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 1,312,109 shares — an estimated $7.91M sold.

Nuveen first reported a position in ACHN in Q2 2013 and held it in 4 quarters. The position peaked at $11.3M in Q3 2019. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.

Nuveen reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
Nuveen sold 1,312,109 Achillion Pharmaceuticals shares in Q1 2020, an estimated $7.91M.
Nuveen first reported a position in Achillion Pharmaceuticals in Q2 2013 and held it in 4 quarters.
Nuveen's Achillion Pharmaceuticals position peaked at $11.3M in Q3 2019.
0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.

Based on Nuveen's 13F filing for Q1 2020, filed 14 May 2020.